| Literature DB >> 35803855 |
Katsuyuki Iwatsuki1, Hiroyuki Hashizume2, Yuki Hara3, Nobuyuki Okui4, Yutaka Morizaki5, Kaoru Tada6, Yuichiro Matsui7, Hisao Ishii8, Hitoshi Hirata9.
Abstract
BACKGROUND: The novel coronavirus (COVID-19) that emerged in 2019 and spread globally in 2020 has resulted in the imposition of lockdowns or a state of emergency in many cities worldwide. In Japan, a "new lifestyle" is being advocated. We hypothesize that the new lifestyle has changed people's use of their upper limbs during the COVID-19 pandemic. Therefore, through this questionnaire study, we aimed to determine the factors associated with exacerbation of symptoms during the pandemic and to investigate the current status of patients who require hand surgery.Entities:
Keywords: COVID-19; Nerve entrapment syndrome; Osteoarthritis; Questionnaire; Smartphone; Tenosynovitis
Year: 2022 PMID: 35803855 PMCID: PMC9236913 DOI: 10.1016/j.jos.2022.06.005
Source DB: PubMed Journal: J Orthop Sci ISSN: 0949-2658 Impact factor: 1.805
Questionnaire about changes in their lifestyles.
| increase | no change | decrease | not performed | |
| increase | no change | decrease | not performed | |
| increase | no change | decrease | not performed | |
| increase | no change | decrease | not performed | |
| increase | no change | decrease | not performed | |
| increase | no change | decrease | not performed | |
| increase | no change | decrease | not performed | |
| increase | no change | decrease | not performed | |
| increase | no change | decrease |
Comparison of “unchanged, improved, and markedly improved” group and “exacerbated and markedly exacerbated” group of symptoms.
| n | unchanged, improved, and markedly improved | n | exacerbated and markedly exacerbated | P-value | |
|---|---|---|---|---|---|
| 252 | 64.1±12.2 | 239 | 63.2±11.5 | 0.403a | |
| 252 | 240 | 0.219b | |||
| Male | 81,32.1 | 65,27.1 | |||
| Female | 171,67.9 | 175,72.9 | |||
| 247 | 235 | ||||
| increase | 26,10.5 | 66,28.1 | |||
| no change | 109,44.1 | 79,33.6 | |||
| decrease | 6,2.4 | 10,4.3 | |||
| not performed | 106,42.9 | 80,34.0 | |||
| 247 | 235 | ||||
| increase | 47,19.0 | 94,40.0 | |||
| no change | 120,48.6 | 84,35.7 | |||
| decrease | 5,2.0 | 5,2.1 | |||
| not performed | 75,30.4 | 52,22.1 | |||
| 248 | 238 | ||||
| increase | 57,23.0 | 75,31.5 | |||
| no change | 132,53.2 | 114,47.9 | |||
| decrease | 20,8.1 | 27,11.3 | |||
| not performed | 39,15.7 | 22,9.2 | |||
| 248 | 238 | 0.243b | |||
| increase | 43,17.3 | 53,22.3 | |||
| no change | 170,68.5 | 147,61.8 | |||
| decrease | 18,7.3 | 25,10.5 | |||
| not performed | 17,6.9 | 13,5.5 | |||
| 247 | 238 | 0.300b | |||
| increase | 15,6.1 | 14,5.9 | |||
| no change | 140,56.7 | 128,53.8 | |||
| decrease | 36,14.6 | 50,21.0 | |||
| not performed | 56,22.7 | 46,19.3 | |||
| 248 | 238 | 0.875b | |||
| increase | 36,14.5 | 35,14.7 | |||
| no change | 171,69.0 | 170,71.4 | |||
| decrease | 7,2.8 | 6,2.5 | |||
| not performed | 34,13.7 | 27,11.3 | |||
| 248 | 236 | ||||
| increase | 17,6.9 | 33,14.0 | |||
| no change | 90,36.3 | 90,38.1 | |||
| decrease | 17,6.9 | 21,8.9 | |||
| not performed | 124,50.0 | 92,39.0 | |||
| 248 | 237 | 0.978b | |||
| increase | 26,10.5 | 23,9.7 | |||
| no change | 124,50.0 | 123,51.9 | |||
| decrease | 72,29.0 | 67,28.3 | |||
| not performed | 26,10.5 | 24,10.1 | |||
| 248 | 237 | 0.066b | |||
| increase | 58,23.4 | 62,26.2 | |||
| no change | 160,64.5 | 131,55.3 | |||
| decrease | 30,12.1 | 44,18.6 |
mean ± sd; n, %.
P-value: a, unpaired t test; b, Chi-squared test.
Univariate analysis for “exacerbated and markedly exacerbated group” (vs. unchanged, improved, and markedly improved group".
| univariate | ||||
|---|---|---|---|---|
| n | OR | 95% CI | P-value | |
| 491 | 0.994 | 0.979,1.009 | 0.402 | |
| 492 | 1.275 | 0.865,1.881 | 0.220 | |
| 482 | ||||
| increase | 92 | 3.502 | 2.044,6.000 | |
| no change | 188 | 1.000 | ref | |
| decrease | 16 | 2.300 | 0.803,6.589 | 0.121 |
| not performed | 186 | 1.041 | 0.691,1.569 | 0.847 |
| 482 | ||||
| increase | 141 | 2.857 | 1.826,4.470 | |
| no change | 204 | 1.000 | ref | |
| decrease | 10 | 1.429 | 0.401,5.090 | 0.582 |
| not performed | 127 | 0.990 | 0.631,1.554 | 0.967 |
| 486 | ||||
| increase | 132 | 1.524 | 0.995,2.333 | 0.053 |
| no change | 246 | 1.000 | ref | |
| decrease | 47 | 1.563 | 0.832,2.936 | 0.165 |
| not performed | 61 | 0.653 | 0.366,1.166 | 0.150 |
| 486 | ||||
| increase | 96 | 1.425 | 0.901,2.255 | 0.130 |
| no change | 317 | 1.000 | ref | |
| decrease | 43 | 1.606 | 0.843,3.061 | 0.150 |
| not performed | 30 | 0.884 | 0.416,1.882 | 0.750 |
| 485 | ||||
| increase | 29 | 1.021 | 0.474,2.198 | 0.958 |
| no change | 268 | 1.000 | ref | |
| decrease | 86 | 1.519 | 0.930,2.482 | 0.095 |
| not performed | 102 | 0.898 | 0.568,1.420 | 0.647 |
| 486 | ||||
| increase | 71 | 0.978 | 0.586,1.631 | 0.932 |
| no change | 341 | 1.000 | ref | |
| decrease | 13 | 0.862 | 0.284,2.619 | 0.794 |
| not performed | 61 | 0.799 | 0.462,1.382 | 0.422 |
| 484 | ||||
| increase | 50 | 1.941 | 1.009,3.733 | |
| no change | 180 | 1.000 | ref | |
| decrease | 38 | 1.235 | 0.612,2.495 | 0.556 |
| not performed | 216 | 0.742 | 0.499,1.104 | 0.141 |
| 485 | ||||
| increase | 49 | 0.892 | 0.483,1.648 | 0.715 |
| no change | 247 | 1.000 | ref | |
| decrease | 139 | 0.938 | 0.619,1.422 | 0.763 |
| not performed | 50 | 0.931 | 0.506,1.710 | 0.817 |
| 485 | ||||
| increase | 120 | 1.306 | 0.853,1.999 | 0.220 |
| no change | 291 | 1.000 | ref | |
| decrease | 74 | 1.791 | 1.067,3.008 | |
OR: Odds ratio, 95% CI: 95% confidence interval, ref: reference standard.
Logistic regression analysis for “exacerbated and markedly exacerbated group” (vs. unchanged, improved, and markedly improved group".
| Model 1: forced entry method with significance for entry of variables | Model 2: logistic regression models with forward selection, based on the likelihood ratio | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| increase | 2.156 | 1.166,3.985 | 2.225 | 1.219,4.064 | ||
| no change | 1.000 | ref | 1.000 | ref | ||
| decrease | 0.909 | 0.562,1.471 | 0.699 | 0.915 | 0.571,1.467 | 0.713 |
| not performed | 1.729 | 0.566,5.277 | 0.336 | 1.995 | 0.667,5.965 | 0.216 |
| increase | 2.244 | 1.258,4.004 | 2.197 | 1.252,3.857 | ||
| no change | 1.000 | ref | 1.000 | ref | ||
| decrease | 1.096 | 0.647,1.858 | 0.733 | 1.019 | 0.609,1.705 | 0.942 |
| not performed | 1.565 | 0.398,6.156 | 0.521 | 1.410 | 0.374,5.314 | 0.612 |
| increase | 2.256 | 1.123,4.535 | ||||
| no change | 1.000 | ref | ||||
| decrease | 1.376 | 0.898,2.107 | 0.143 | |||
| not performed | 1.572 | 0.741,3.333 | 0.238 | |||
| increase | 0.573 | 0.293,1.121 | 0.104 | |||
| no change | 1.000 | ref | ||||
| decrease | 0.675 | 0.376,1.215 | 0.190 | |||
OR: Odds ratio, 95% CI: 95% confidence interval, ref: reference standard.